SERB
Location
ILE DE FRANCE
Founded
1951-07-25
Website
Risk Signals
36 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Acquisition Announcements (8)
Financial Reporting (4)
Business Litigation (3)
Corporate Deals (3)
Earnings Reports & Warnings (3)
Asset Divestment (3)
Corporate Social Responsibility Initiatives (2)
Labor Law and Employment Regulations (2)
Healthcare Compliance and Regulations (2)
Fintech Innovations (1)
Freelance and On-Demand Workforces (1)
Global Diplomacy and Conflicts (1)
Global Political Disputes (1)
Joint Ventures (1)
Market Entry (1)
Private Equity Buyouts (1)
Research and Development (1)
Strategic Partnerships (1)
Business Agreements (1)
Talent Development and Training (1)
Business Growth Initiatives (1)
Cross-Border Mergers (1)
Diversity and Inclusion Programs (1)
Economic Indicators (1)
Employee Compensation and Benefits (1)
Executive Speeches and Presentations (1)
Recent Articles about SERB
Live alerts from global media, monitored by Business Radar
2025-07-01 (pharmatutor.org)
ANRRF Invites application for Inclusivity Research Grant |
IRG subsumes the Empowerment and Equity Opportunities for Excellence in Science (EMEQ) scheme of erstwhile SERB. IRG will provide enhanced support with flexible norms.
Read more